Bacterial extracellular vesicles
OwnerBrian Goodman, Baundauna Bose +1inventors
InventorsBrian Goodman, Baundauna Bose, Christopher J. H. Davitt
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions related to EVs useful as therapeutic agents.
Claims19
A method of treating an immune disorder in a subject comprising administering to the subject a pharmaceutical composition comprising isolated bacterial extracellular vesicles (EVs), wherein at least 90% of the total EV and bacteria particles in the pharmaceutical composition are EVs from Prevotella or Veillonella bacteria.
A method of treating psoriasis or atopic dermatitis in a subject comprising orally administering to the subject a pharmaceutical composition comprising isolated bacterial extracellular vesicles (EVs), wherein at least 90% of the total EV and bacteria particles in the pharmaceutical compositions are EVs from Prevotella histicola bacteria.
A method of treating psoriasis or atopic dermatitis in a subject comprising orally administering to the subject a pharmaceutical composition comprising isolated bacterial extracellular vesicles (EVs), wherein at least 90% of the total EV and bacteria particles in the pharmaceutical compositions are EVs from Veillonella tobetsuensis bacteria or Veillonella parvula bacteria.
Dependencies are inferred from the claim text.